RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Vigilance Reporting for Medical Devices in the EU

Vigilance Reporting for Medical Devices in the EU

Posted 01 September 2009

Manufacturers putting medical devices on the market in the European Union (EU) must have a vigilance system in place for collecting and evaluating reported incidents and taking corrective action if necessary to prevent the recurrence of such incidents. The main purpose of a medical device vigilance system is to improve protection of patients' and other users' health and safety by reducing the likelihood that a device incident will recur.1 At a higher level, the vigilance system is an integral part of a postmarket surveillance (PMS) system.

 

© 2022 Regulatory Affairs Professionals Society.